PT - JOURNAL ARTICLE AU - Nathan T. Carrington AU - Paul W. Milhouse AU - Caleb J. Behrend AU - Tom B. Pace AU - Jeffrey N. Anker AU - John D. DesJardins TI - Measuring Intertrochanteric Fracture Stability with a Novel Strain-Sensing Sliding Hip Screw AID - 10.1101/2020.09.04.20183251 DP - 2020 Jan 01 TA - medRxiv PG - 2020.09.04.20183251 4099 - http://medrxiv.org/content/early/2020/09/07/2020.09.04.20183251.short 4100 - http://medrxiv.org/content/early/2020/09/07/2020.09.04.20183251.full AB - Background Bone healing after internal fixation of intertrochanteric hip fractures is difficult to monitor with radiography, particularly with internal fixation implants such as the sliding hip screw (SHS). In this study, we evaluate a robust, user-friendly device to non-invasively determine the loading on the screw implant. This will allow clinicians to better monitor the status of bone healing and take preventative steps if complications occur.Methods A novel strain-sensing sliding hip screw (SS-SHS) was designed and refined using a finite element model of a simple intertrochanteric fracture and a standard SHS implant. The SS-SHS houses an internally fixed indicator rod, whose position relative to the screw body can be viewed on plain film radiographs to measure screw bending. Screw bending was assessed in an intact femur and an unstable A1 intertrochanteric fracture using a finite element computational model and compared with experimental axial loading of a femoral Sawbones composite and human cadaveric femur specimens. Indicator rod position relative to the screw was visually tracked using plain radiographs at each load state.Results The indicator rod was found to displace linearly in response to implant strain in the unstable fracture. This movement was consistently visible and measurable using radiography throughout loading cycles across the mechanical and cadaveric fracture models. Sensor movement was not detected in healed fracture models. The slope of the curve was approximately equal in the computations, composite and cadaveric models (0.08 µm/N, 1.0 µm/N, 0.08 µm/N, respectively). The noise level was approximately 25 N in the composite model and 63 N in the cadaveric specimen and this was sufficient to see 1/10th of body weight or more for an 80 kg patient which is likely good enough to track fracture healing.Conclusions In current practice, clinicians must carefully monitor their patients for signs of implant failure after surgery. However, by the time signs of failure are apparent, it is often too late to avoid revision surgery. This device enables clinicians to quantitatively track fracture healing, and better communicate the process to the patient. Clinicians can also take preventive measures with at-risk patients before revision surgery is needed, thus reducing mortality risks.Clinical Relevance By augmenting an existing SHS system with an indicator rod, crucial information on the status of fracture healing can be ascertained from follow-up radiographs already taken with no additional risk to the patient.Competing Interest StatementJNA, CJB, and JDD are inventors on related US Patent US10667745B2 and founders of Aravis BioTech LLC, which has licensed the rights to the patent from Clemson.Funding StatementThis work was funded by National Institute of Health (NIH) under COBRE grant 5 P20 GM103444-07 and 1R21EB019709-01A1. (PI: Jeffrey N Anker)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Clemson University Institutional Review Board (IRB) had determined that the mechanical testing of cadaveric specimens without identifiable private information does not constitute human subjects research in accordance with 45 CFR 46.102(e) and is exempt from IRB oversight. Donors consented their bodies to be used for medical education and research in accordance with Uniform Anatomical Gift Act and the research was performed in accordance with the Clemson University Institutional Biosafety Committee. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the corresponding author, NTC, upon reasonable request.